Responding to a medical device manufacturer’s contention in a case brought against it under the False Claims Act (FCA) that the law’s qui tam provisions are unconstitutional, the Department of Justice (DOJ) has filed a statement of interest in the case, calling for the provisions of the statute — which the department called “the United States’ primary civil tool for prosecutin... Read More